20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

News

BioGenerator News

BioGenerator Portfolio Company Finds Success in St. Louis

Oct 03, 2014

BioGenerator congratulates its portfolio company, Adarza BioSystems, on closing a $6.8 million Series A financing round and its plans to expand its St. Louis presence. BioGenerator, an entrepreneurial support and […]

Read More

St. Louis’ BioGenerator Named among Best Practices in the Western Hemisphere

Dec 12, 2013

The BioGenerator has been recognized as a Center of Best Practice in the second annual “Signs of Competitiveness in the America’s” report from the Inter- American Competitiveness Network under the […]

Read More

BioGenerator Wins National Award of Excellence for Advancing Regional Competitiveness

Sep 16, 2013

BioGenerator was named a winner of SSTI’s 2013 “Excellence in TBED” (technology-based economic development) award, recognizing BioGenerator and its programs as national models for investing in science, technology and innovation […]

Read More

BioGenerator Adds 4 Industry Experts to Entrepreneur In Residence Program

Aug 05, 2013

Four additional Entrepreneurs In Residence (EIRs) have joined the BioGenerator, bringing the organization’s roster of EIRs to 12 – up from five last summer. The EIRs will support the creation […]

Read More

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

Apr 17, 2013

BioGenerator recently led syndication of investment in Adarza  BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business […]

Read More

BioGenerator Invests in Antegrin Therapeutics

Apr 02, 2013

BioGenerator – the non-profit venture development organization of BioSTL – recently closed on an investment in Antegrin Therapeutics through its i6 Project Fund.  The investment will allow Antegrin to select […]

Read More

BioGenerator Investment Helps Relocate Tansna Therapeutics to St. Louis

Feb 19, 2013

BioGenerator – the non-profit venture development organization of BioSTL – recently closed on a Spark Fund investment in Tansna Therapeutics, Inc., to support further commercialization of the company’s epilepsy drugs […]

Read More

BioGenerator Adds Additional Industry Expert to Entrepreneur-in-Residence Program

Feb 07, 2013

Dr. Cheryl Watkins-Moore has joined as an Entrepreneur-in- Residence (EIR) with the BioGenerator – the non-profit venture development organization of BioSTL – to create, lead, and support new bioscience companies […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors